Furthermore, among the differentially expressed genes associated with melanoma, the combination group significantly suppressed the transcript levels of key genes such as mitf, cdk2, and tyr (Figure 4E), highlighting its potential therapeutic efficacy. This evidence concerns the gene CDK2 and melanoma.